SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Bueno de Mesquita H. B. Bas)
 

Sökning: WFRF:(Bueno de Mesquita H. B. Bas) > Tumor necrosis fact...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00009182naa a2200925 4500
001oai:DiVA.org:umu-41629
003SwePub
008110330s2011 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-416292 URI
024a https://doi.org/10.1002/ijc.258402 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Dossus, Laureu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
2451 0a Tumor necrosis factor (TNF)-α, soluble TNF receptors and endometrial cancer risk :b the EPIC study
264 c 2011-03-08
264 1a Geneve :b International union against cancer,c 2011
338 a print2 rdacarrier
520 a Chronic inflammation has been hypothesized to play a role in endometrial cancer development. Tumor necrosis factor-α (TNF-α), one of the major pro-inflammatory cytokines, has also been implicated in endometrial physiology. We conducted a case-control study nested within the European prospective investigation into cancer and nutrition (EPIC) to examine the association of TNF-α and its two soluble receptors (sTNFR1 and sTNFR2) with endometrial cancer risk. Two-hundred-seventy cases and 518 matched controls were analyzed using conditional logistic regression. All statistical tests were two-sided. We observed an increased risk of endometrial cancer among women in the highest versus lowest quartile of TNF-α (odds ratio [OR]: 1.73, 95% CI: 1.09-2.73, Ptrend = 0.01), sTNFR1 (OR: 1.68, 95% CI: 0.99-2.86, Ptrend = 0.07) and sTNFR2 (OR: 1.53, 95%CI: 0.92-2.55, Ptrend = 0.03) after adjustment for body-mass-index, parity, age at menopause and previous postmenopausal hormone therapy use. Further adjustments for estrogens and C-peptide had minor effect on risk estimates. Our data show that elevated prediagnostic concentrations of TNF-α and its soluble receptors are related to a higher risk of endometrial cancer, particularly strong in women diagnosed within 2 years of blood donation. This is the first study of its kind and therefore deserves replication in further prospective studies.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
653 a tumor necrosis factor (TNF)-α
653 a soluble TNF receptors
653 a inflammation
653 a endometrial cancer
653 a prospective
653 a MEDICINE
653 a MEDICIN
653 a Pathology
653 a patologi
700a Becker, Susenu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
700a Rinaldi, Sabinau Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France4 aut
700a Lukanova, Annekatrinu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
700a Tjønneland, Anneu Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark4 aut
700a Olsen, Anjau Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark4 aut
700a Overvad, Kimu Department of Epidemiology, School of Public Health, Aarhus University, Aarhus, Denmark4 aut
700a Chabbert-Buffet, Nathalieu Department of Obstetrics and Gynecology, APHP Hospital Tenon and UMPC, Paris, France4 aut
700a Boutron-Ruault, Marie-Christineu INSERM, Centre for Research in Epidemiology and Population Health, Paris South University, Gustave Roussy Institute, Villejuif, France4 aut
700a Clavel-Chapelon, Françoiseu INSERM, Centre for Research in Epidemiology and Population Health, Paris South University, Gustave Roussy Institute, Villejuif, France4 aut
700a Teucher, Birgitu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
700a Chang-Claude, Jennyu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
700a Pischon, Tobiasu Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany4 aut
700a Boeing, Heineru Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany4 aut
700a Trichopoulou, Antoniau Department of Hygiene, Epidemiology and Medical Statistics, WHO Collaborating Center for Food and Nutrition Policies, University of Athens Medical School, Athens, Greece4 aut
700a Benetou, Vasilikiu Department of Hygiene, Epidemiology and Medical Statistics, WHO Collaborating Center for Food and Nutrition Policies, University of Athens Medical School, Athens, Greece4 aut
700a Valanou, Elisavetu Department of Hygiene, Epidemiology and Medical Statistics, WHO Collaborating Center for Food and Nutrition Policies, University of Athens Medical School, Athens, Greece4 aut
700a Palli, Domenicou Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute (ISPO), Florence, Italy4 aut
700a Sieri, Sabinau Department of Preventive and Predictive Medicine, Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy4 aut
700a Tumino, Rosariou Cancer Registry and Histopathology Unit, “Civile – M.P. Arezzo” Hospital, Ragusa, Italy4 aut
700a Sacerdote, Carlottau Center for Cancer Prevention (CPO Piedmont), Turin, Italy4 aut
700a Galasso, Roccou Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS-CROOB), Rionero in Vulture (PZ), Italy4 aut
700a Redondo, Maria-Luísau Public Health and Participation Directorate, Health and Health Care Services Council, Asturias, Spain4 aut
700a Bonet Bonet, Catalinau Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Barcelona, Spain4 aut
700a Molina-Montes, Estheru Andalusian School of Public Health, Granada, Spain4 aut
700a Altzibar, Jone Mu CIBER de Epidemiología y Salud Pública (CIBERESP), Spain4 aut
700a Chirlaque, Maria-Doloresu CIBER de Epidemiología y Salud Pública (CIBERESP), Spain4 aut
700a Ardanaz, Evau CIBER de Epidemiología y Salud Pública (CIBERESP), Spain4 aut
700a Bueno-de-Mesquita, H Basu CIBER de Epidemiología y Salud Pública (CIBERESP), Spain4 aut
700a van Duijnhoven, Fränzel J Bu National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands4 aut
700a Peeters, Petra H Mu Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands4 aut
700a Onland-Moret, N Charlotteu Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands4 aut
700a Lundin, Evau Umeå universitet,Patologi4 aut0 (Swepub:umu)evlu0001
700a Idahl, Annikau Umeå universitet,Obstetrik och gynekologi,Institutionen för folkhälsa och klinisk medicin4 aut0 (Swepub:umu)anid0002
700a Khaw, Kay-Teeu Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom4 aut
700a Wareham, Nicholasu MRC Epidemiology Unit, Cambridge, United Kingdom4 aut
700a Allen, Naomiu Nuffield Department of Clinical Medicine, Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom4 aut
700a Romieu, Isabelleu International Agency for Research on Cancer, Lyon, France4 aut
700a Fedirko, Veronikau International Agency for Research on Cancer, Lyon, France4 aut
700a Hainaut, Pierreu Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom4 aut
700a Romaguera, Dorau Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom4 aut
700a Norat, Teresau Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom4 aut
700a Riboli, Eliou Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, United Kingdom4 aut
700a Kaaks, Rudolfu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
710a Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germanyb Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France4 org
773t International Journal of Cancerd Geneve : International union against cancerg 129:8, s. 2032-2037q 129:8<2032-2037x 0020-7136x 1097-0215
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.25840
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-41629
8564 8u https://doi.org/10.1002/ijc.25840

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy